Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-08-13

Clinical Trial Update: Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated whether the skin disinfectant octenidine dihydrochloride can prevent catheter-associated infections during central venous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Octenidine Dihydrochloride (octenidine dihydrochloride)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Catheterization, Central Venous, Catheter-Associated Infections | Phase 4 | Status: COMPLETED